Garde Capital, Inc. - SELECT SECTOR SPDR TR ownership

SELECT SECTOR SPDR TR's ticker is XLK and the CUSIP is 81369Y803. A total of 1,648 filers reported holding SELECT SECTOR SPDR TR in Q3 2023. The put-call ratio across all filers is 1.76 and the average weighting 0.7%.

Quarter-by-quarter ownership
Garde Capital, Inc. ownership history of SELECT SECTOR SPDR TR
ValueSharesWeighting
Q3 2023$911
-6.6%
5,556
-0.9%
0.08%
-3.7%
Q2 2023$975
+14.6%
5,609
-0.5%
0.08%
-12.9%
Q1 2023$851
+21.2%
5,639
+0.0%
0.09%
+10.7%
Q4 2022$702
-99.9%
5,638
+11.1%
0.08%
+7.7%
Q3 2022$603,000
+13.1%
5,073
+21.1%
0.08%
+20.0%
Q2 2022$533,000
-7.1%
4,189
+15.9%
0.06%
+10.2%
Q1 2022$574,000
-8.6%
3,6140.0%0.06%
-3.3%
Q4 2021$628,000
+16.1%
3,614
-0.2%
0.06%
+8.9%
Q3 2021$541,000
-3.9%
3,622
-5.0%
0.06%
-3.4%
Q2 2021$563,000
+11.0%
3,8140.0%0.06%
-1.7%
Q1 2021$507,000
+2.4%
3,8140.0%0.06%
-1.7%
Q4 2020$495,000
+13.0%
3,814
+1.7%
0.06%
-9.1%
Q3 2020$438,000
+11.7%
3,7490.0%0.07%
+15.8%
Q2 2020$392,000
+30.2%
3,7490.0%0.06%
+7.5%
Q1 2020$301,000
+16.7%
3,749
+33.3%
0.05%
+43.2%
Q4 2019$258,000
+14.2%
2,8120.0%0.04%
+5.7%
Q3 2019$226,000
+3.2%
2,8120.0%0.04%
-2.8%
Q2 2019$219,000
+5.3%
2,8120.0%0.04%0.0%
Q1 2019$208,000
+2.5%
2,812
-14.1%
0.04%0.0%
Q4 2018$203,000
-4.7%
3,275
+5.2%
0.04%0.0%
Q3 2018$213,000
-1.4%
3,1130.0%0.04%
-2.7%
Q2 2018$216,000
+5.9%
3,1130.0%0.04%0.0%
Q1 2018$204,0003,1130.04%
Other shareholders
SELECT SECTOR SPDR TR shareholders Q3 2023
NameSharesValueWeighting ↓
Bellwether Advisors, LLC 334,147$54,776,71814.91%
J.Safra Asset Management Corp 585,610$95,999,04713.99%
TIFF ADVISORY SERVICES, LLC 94,475$15,487,28712.80%
Sequent Asset Management, LLC 70,981$11,635,91612.76%
Ciovacco Capital Management LLC 93,644$15,35112.73%
CHURCHILL MANAGEMENT Corp 4,408,631$722,706,88512.22%
Parker Investment Management, LLC 334,270$54,796,92911.83%
Mendel Capital Management LLC 86,397$14,163,12811.63%
WestEnd Advisors, LLC 2,343,405$384,154,49111.55%
Wall Capital Group, Inc. 47,157$8,067,66711.46%
View complete list of SELECT SECTOR SPDR TR shareholders